These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24524664)

  • 1. Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
    Quinones LA; Lavanderos MA; Cayun JP; Garcia-Martin E; Agundez JA; Caceres DD; Roco AM; Morales JE; Herrera L; Encina G; Isaza CA; Redal MA; Larovere L; Soria NW; Eslava-Schmalbach J; Castaneda-Hernandez G; Lopez-Cortes A; Magno LA; Lopez M; Chiurillo MA; Rodeiro I; Castro de Guerra D; Teran E; Estevez-Carrizo F; Lares-Assef I
    Curr Drug Metab; 2014 Feb; 15(2):202-8. PubMed ID: 24524664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean.
    Salas-Hernández A; Galleguillos M; Carrasco M; López-Cortés A; Redal MA; Fonseca-Mendoza D; Esperón P; González-Martínez F; Lares-Asseff I; Lazarowski A; Loera-Castañeda V; Remírez D; Martínez MF; Vargas R; Rios-Santos F; Macho A; Cayún JP; Perez GR; Gutierrez C; Cerpa LC; Leiva T; Calfunao S; Xajil L; Sandoval C; Suárez M; Gonzalez A; Echeverría-Garcés G; Sullón-Dextre L; Cordero-García E; Morales AR; Avendaño A; Sánchez E; Bastone LC; Lara C; Zuluaga-Arias P; Soler AM; Da Luz J; Burgueño-Rodríguez G; Vital M; Reyes-Reyes E; Huaccha A; Ariza YV; Tzul N; Rendón AL; Serrano R; Acosta L; Motta-Pardo A; Beltrán-Angarita L; Brand E; Jiménez MA; Hidalgo-Lozada GM; Romero-Prado MMJ; Escobar-Castro K; Umaña-Rivas M; Vivas JD; Lagos P; Martínez YB; Quesada S; Calfio C; Arias ML; Lavanderos MA; Cáceres DD; Salazar-Granara A; Varela NM; Quiñones LA
    Front Pharmacol; 2023; 14():1175737. PubMed ID: 37251329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics.
    Becquemont L; Alfirevic A; Amstutz U; Brauch H; Jacqz-Aigrain E; Laurent-Puig P; Molina MA; Niemi M; Schwab M; Somogyi AA; Thervet E; Maitland-van der Zee AH; van Kuilenburg AB; van Schaik RH; Verstuyft C; Wadelius M; Daly AK
    Pharmacogenomics; 2011 Jan; 12(1):113-24. PubMed ID: 21174626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
    Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
    Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of pharmacogenetics to pharmacovigilance.
    Bondon-Guitton E; Despas F; Becquemont L
    Therapie; 2016 Apr; 71(2):223-8. PubMed ID: 27080842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
    Becquemont L
    Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of pharmacogenomics in adverse drug reactions.
    Cacabelos R; Cacabelos N; Carril JC
    Expert Rev Clin Pharmacol; 2019 May; 12(5):407-442. PubMed ID: 30916581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain.
    Agúndez JA; Abad-Santos F; Aldea A; Alonso-Navarro H; Bernal ML; Borobia AM; Borrás E; Carballo M; Carvajal A; García-Muñiz JD; Gervasini G; Jiménez-Jiménez FJ; Lucena MI; Martínez C; Sacristán JA; Salado I; Sinués B; Vicente J; García-Martín E
    Front Genet; 2012; 3():273. PubMed ID: 23233861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?
    Fan M; Bousman CA
    Pharmacopsychiatry; 2020 Jul; 53(4):174-178. PubMed ID: 30900236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.
    Drozda K; Müller DJ; Bishop JR
    Pharmacotherapy; 2014 Feb; 34(2):166-84. PubMed ID: 24523097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
    Bousman C; Maruf AA; Müller DJ
    Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
    Pratt VM; Everts RE; Aggarwal P; Beyer BN; Broeckel U; Epstein-Baak R; Hujsak P; Kornreich R; Liao J; Lorier R; Scott SA; Smith CH; Toji LH; Turner A; Kalman LV
    J Mol Diagn; 2016 Jan; 18(1):109-23. PubMed ID: 26621101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.
    Hertz DL; Bousman CA; McLeod HL; Monte AA; Voora D; Orlando LA; Crutchley RD; Brown B; Teeple W; Rogers S; Patel JN
    Am J Health Syst Pharm; 2024 Aug; 81(16):672-683. PubMed ID: 38652504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
    Mizzi C; Dalabira E; Kumuthini J; Dzimiri N; Balogh I; Başak N; Böhm R; Borg J; Borgiani P; Bozina N; Bruckmueller H; Burzynska B; Carracedo A; Cascorbi I; Deltas C; Dolzan V; Fenech A; Grech G; Kasiulevicius V; Kádaši Ľ; Kučinskas V; Khusnutdinova E; Loukas YL; Macek M; Makukh H; Mathijssen R; Mitropoulos K; Mitropoulou C; Novelli G; Papantoni I; Pavlovic S; Saglio G; Setric J; Stojiljkovic M; Stubbs AP; Squassina A; Torres M; Turnovec M; van Schaik RH; Voskarides K; Wakil SM; Werk A; Del Zompo M; Zukic B; Katsila T; Lee MT; Motsinger-Rief A; Mc Leod HL; van der Spek PJ; Patrinos GP
    PLoS One; 2016; 11(9):e0162866. PubMed ID: 27636550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pharmacogenomics on clinical practice in oncology.
    Marsh S
    Mol Diagn Ther; 2007; 11(2):79-82. PubMed ID: 17397243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in chronic pain therapy: from disease to treatment and challenges for clinical practice.
    Yamamoto PA; Conchon Costa AC; Lauretti GR; de Moraes NV
    Pharmacogenomics; 2019 Aug; 20(13):971-982. PubMed ID: 31486733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conference scene: Latin American Pharmacogenomics and Personalized Medicine Conference.
    Suarez-Kurtz G
    Pharmacogenomics; 2012 Oct; 13(13):1449-52. PubMed ID: 23057544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.